Cargando…
Current cancer burden in China: epidemiology, etiology, and prevention
Cancer has become the most common cause of death in China. Owing to rapid economic development, improved livelihood, and shifts in risk factors, cancer epidemiology has experienced substantial changes during the past several decades. In this review, we aim to describe the current cancer epidemiology...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Compuscript
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9425189/ https://www.ncbi.nlm.nih.gov/pubmed/36069534 http://dx.doi.org/10.20892/j.issn.2095-3941.2022.0231 |
_version_ | 1784778394158759936 |
---|---|
author | Cao, Maomao Li, He Sun, Dianqin He, Siyi Yan, Xinxin Yang, Fan Zhang, Shaoli Xia, Changfa Lei, Lin Peng, Ji Chen, Wanqing |
author_facet | Cao, Maomao Li, He Sun, Dianqin He, Siyi Yan, Xinxin Yang, Fan Zhang, Shaoli Xia, Changfa Lei, Lin Peng, Ji Chen, Wanqing |
author_sort | Cao, Maomao |
collection | PubMed |
description | Cancer has become the most common cause of death in China. Owing to rapid economic development, improved livelihood, and shifts in risk factors, cancer epidemiology has experienced substantial changes during the past several decades. In this review, we aim to describe the current cancer epidemiology of the main types of cancer in China, report major risk factors associated with cancer development, and summarize the contributions of the Chinese government to controlling the cancer burden. A total of 4,064,000 new cases were diagnosed in China in 2016. The most frequent types are lung cancer (828,100; 20.4%), colorectal cancer (408,000; 10.0%), and gastric cancer (396,500; 9.8%). Lung (657,000; 27.2%), liver (336,400, 13.9%), and stomach (288,500; 12.0%) cancers are the 3 most deadly cancers in the general population. The 5-year survival rate for cancer has dramatically increased in recent decades. However, liver and particularly pancreatic cancers still have the poorest prognosis. The main modifiable risk factors associated with cancer development include infectious agents, smoking, alcohol consumption, obesity, unhealthful dietary habits, and inadequate physical activity. The Chinese government has made unremitting efforts to decrease the cancer burden, including cancer education and investment in cancer screening programs. |
format | Online Article Text |
id | pubmed-9425189 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Compuscript |
record_format | MEDLINE/PubMed |
spelling | pubmed-94251892022-09-16 Current cancer burden in China: epidemiology, etiology, and prevention Cao, Maomao Li, He Sun, Dianqin He, Siyi Yan, Xinxin Yang, Fan Zhang, Shaoli Xia, Changfa Lei, Lin Peng, Ji Chen, Wanqing Cancer Biol Med Review Cancer has become the most common cause of death in China. Owing to rapid economic development, improved livelihood, and shifts in risk factors, cancer epidemiology has experienced substantial changes during the past several decades. In this review, we aim to describe the current cancer epidemiology of the main types of cancer in China, report major risk factors associated with cancer development, and summarize the contributions of the Chinese government to controlling the cancer burden. A total of 4,064,000 new cases were diagnosed in China in 2016. The most frequent types are lung cancer (828,100; 20.4%), colorectal cancer (408,000; 10.0%), and gastric cancer (396,500; 9.8%). Lung (657,000; 27.2%), liver (336,400, 13.9%), and stomach (288,500; 12.0%) cancers are the 3 most deadly cancers in the general population. The 5-year survival rate for cancer has dramatically increased in recent decades. However, liver and particularly pancreatic cancers still have the poorest prognosis. The main modifiable risk factors associated with cancer development include infectious agents, smoking, alcohol consumption, obesity, unhealthful dietary habits, and inadequate physical activity. The Chinese government has made unremitting efforts to decrease the cancer burden, including cancer education and investment in cancer screening programs. Compuscript 2022-08-15 2022-08-30 /pmc/articles/PMC9425189/ /pubmed/36069534 http://dx.doi.org/10.20892/j.issn.2095-3941.2022.0231 Text en Copyright: © 2022, Cancer Biology & Medicine https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY) 4.0 (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Review Cao, Maomao Li, He Sun, Dianqin He, Siyi Yan, Xinxin Yang, Fan Zhang, Shaoli Xia, Changfa Lei, Lin Peng, Ji Chen, Wanqing Current cancer burden in China: epidemiology, etiology, and prevention |
title | Current cancer burden in China: epidemiology, etiology, and prevention |
title_full | Current cancer burden in China: epidemiology, etiology, and prevention |
title_fullStr | Current cancer burden in China: epidemiology, etiology, and prevention |
title_full_unstemmed | Current cancer burden in China: epidemiology, etiology, and prevention |
title_short | Current cancer burden in China: epidemiology, etiology, and prevention |
title_sort | current cancer burden in china: epidemiology, etiology, and prevention |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9425189/ https://www.ncbi.nlm.nih.gov/pubmed/36069534 http://dx.doi.org/10.20892/j.issn.2095-3941.2022.0231 |
work_keys_str_mv | AT caomaomao currentcancerburdeninchinaepidemiologyetiologyandprevention AT lihe currentcancerburdeninchinaepidemiologyetiologyandprevention AT sundianqin currentcancerburdeninchinaepidemiologyetiologyandprevention AT hesiyi currentcancerburdeninchinaepidemiologyetiologyandprevention AT yanxinxin currentcancerburdeninchinaepidemiologyetiologyandprevention AT yangfan currentcancerburdeninchinaepidemiologyetiologyandprevention AT zhangshaoli currentcancerburdeninchinaepidemiologyetiologyandprevention AT xiachangfa currentcancerburdeninchinaepidemiologyetiologyandprevention AT leilin currentcancerburdeninchinaepidemiologyetiologyandprevention AT pengji currentcancerburdeninchinaepidemiologyetiologyandprevention AT chenwanqing currentcancerburdeninchinaepidemiologyetiologyandprevention |